Global Information
회사소개 | 문의 | 위시리스트

세계의 응급 피임약 시장(2018-2022년)

Global Emergency Contraceptive Pill Market 2018-2022

리서치사 TechNavio (Infiniti Research Ltd.)
발행일 2018년 07월 상품 코드 666009
페이지 정보 영문 104 Pages
가격
US $ 2,500 ₩ 2,988,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 3,000 ₩ 3,586,000 PDF by E-mail (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,000 ₩ 4,781,000 PDF by E-mail (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 5,977,000 PDF by E-mail (Global License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다. 또한 해당 라이선스는 보고서 컨텐츠의 15% 이내로 외부용 문서에 인용 게재가 허용됩니다(예:프레스릴리스, 마케팅 자료, 백서 등).


세계의 응급 피임약 시장(2018-2022년) Global Emergency Contraceptive Pill Market 2018-2022
발행일 : 2018년 07월 페이지 정보 : 영문 104 Pages

응급 피임약에 대해

응급 피임약은 단기간 피임법이며, 비보호 성관계, 성폭행, 피임약 복용 중지 또는 계획에 없던 임신을 방지하기 위한 콘돔 파손의 72시간 이내에 소비해야 합니다.

Technavio의 애널리스트는 2018-2022년간 세계의 응급 피임약 시장이 2.55%의 연평균 성장률(CAGR)로 성장할 것으로 예측했습니다.

세계의 응급 피임약(Emergency Contraceptive Pill) 시장에 대해 조사 분석했으며, 시장 규모와 성장률, 시장 동향, 시장 성장 촉진요인과 과제, 시장 기회, 주요 벤더 등의 정보를 전해드립니다.

목차

제1장 주요 요약

제2장 조사 범위

제3장 조사 방법

제4장 시장 상황

  • 시장 생태계
  • 시장 특성
  • 시장 세분화 분석

제5장 시장 규모

  • 시장 정의
  • 시장 규모(2017년)
  • 시장 규모 및 예측(2017-2022년)

제6장 Five Forces 분석

  • 구매자의 협상력
  • 공급업체의 협상력
  • 신규 참여업체의 위협
  • 대체품의 위협
  • 경쟁사의 위협
  • 시장 상황

제7장 시장 세분화 : 유통 경로별

  • 세분화 : 유통 경로별
  • 비교 : 유통 경로별
  • 소매점
  • 온라인 스토어
  • 시장 기회 : 유통 경로별

제8장 고객 상황

제9장 지역 상황

  • 지역별 세분화(2017-2022년)
  • 지역 비교
  • 아메리카
  • 유럽, 중동 및 아프리카
  • 아시아태평양
  • 시장 기회

제10장 의사결정 체계

제11장 성장요인과 과제

  • 시장 성장요인
  • 시장 과제

제12장 시장 동향

  • 가족 계획의 중요성
  • 온라인 앱의 출현
  • 가처분 소득의 증가

제13장 벤더 상황

  • 개요
  • 창조적 파괴 상황

제14장 벤더 분석

  • 대상 벤더
  • 벤더 분류
  • 벤더의 시장 포지셔닝
  • LUPIN
  • Mankind Pharma
  • Perrigo
  • Piramal Enterprises
  • Sun Pharmaceutical Industries

제15장 부록

  • 약어 리스트
KSM 18.08.02

About Emergency Contraceptive Pill

An emergency contraceptive pill is a short-term method of contraception that needs to be consumed within 72 hours of unprotected sexual intercourse, sexual assault, lapse in taking birth control pills, or condom breakage to prevent an unplanned pregnancy.

Technavio's analysts forecast the Global Emergency Contraceptive Pill Market to grow at a CAGR of 2.55% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the emergency contraceptive pill market. To calculate the market size, the report considers the revenue generated from the sales of emergency contraceptive pill.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Emergency Contraceptive Pill Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • LUPIN
  • Mankind Pharma
  • Perrigo
  • Piramal Enterprises
  • Sun Pharmaceutical Industries

Market driver

  • Rise in the number of initiatives to create awareness
  • For a full, detailed list, view our report

Market challenge

  • Local governments limiting access to emergency contraceptive pills
  • For a full, detailed list, view our report

Market trend

  • Advent of online apps
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY DISTRIBUTION CHANNEL

  • Segmentation by distribution channel
  • Comparison by distribution channel
  • Retail stores
  • Online stores
  • Market opportunity by distribution channel

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Americas- Market size and forecast 2017-2022
  • EMEA - Market size and forecast 2017-2022
  • APAC - Market size and forecast 2017-2022
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Importance of family planning
  • Advent of online apps
  • Rising disposable income

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • LUPIN
  • Mankind Pharma
  • Perrigo
  • Piramal Enterprises
  • Sun Pharmaceutical Industries

PART 15: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Parent market
  • Exhibit 02: Global female contraceptive market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2017
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global emergency contraceptive pill 2017-2022 ($ mn)
  • Exhibit 09: Global emergency contraceptive pill market - Year-over-year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2017
  • Exhibit 18: Global emergency contraceptive pill market by distribution channel - Market share 2017-2022 (%)
  • Exhibit 19: Comparison by distribution channel
  • Exhibit 20: Retail stores - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 21: Retail stores - Year-over-year growth 2018-2022 (%)
  • Exhibit 22: Online stores - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 23: Online stores - Year-over-year growth 2018-2022 (%)
  • Exhibit 24: Market opportunity by distribution channel
  • Exhibit 25: Customer landscape
  • Exhibit 26: Global emergency contraceptive pill market by geography - Market share 2017-2022 (%)
  • Exhibit 27: Regional comparison
  • Exhibit 28: Americas - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 29: Americas - Year-over-year growth 2018-2022 (%)
  • Exhibit 30: Top three countries in Americas
  • Exhibit 31: EMEA - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 32: EMEA - Year-over-year growth 2018-2022 (%)
  • Exhibit 33: Top three countries in EMEA
  • Exhibit 34: APAC - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 35: APAC - Year-over-year growth 2018-2022 (%)
  • Exhibit 36: Top three countries in APAC
  • Exhibit 37: Market opportunity
  • Exhibit 38: Vendor landscape
  • Exhibit 39: Landscape disruption
  • Exhibit 40: Vendors covered
  • Exhibit 41: Vendor classification
  • Exhibit 42: Market positioning of vendors
  • Exhibit 43: LUPIN overview
  • Exhibit 44: LUPIN - Business segments
  • Exhibit 45: LUPIN- Organizational developments
  • Exhibit 46: LUPIN- Geographic focus
  • Exhibit 47: LUPIN - Key offerings
  • Exhibit 48: Mankind Pharma overview
  • Exhibit 49: Mankind Pharma - Business segments
  • Exhibit 50: Mankind Pharma - Organizational developments
  • Exhibit 51: Mankind Pharma - Segment focus
  • Exhibit 52: Mankind Pharma - Key offerings
  • Exhibit 53: Perrigo overview
  • Exhibit 54: Perrigo- Business segments
  • Exhibit 55: Perrigo- Organizational developments
  • Exhibit 56: Perrigo- Geographic focus
  • Exhibit 57: Perrigo- Segment focus
  • Exhibit 58: Perrigo- Key offerings
  • Exhibit 59: Piramal Enterprises overview
  • Exhibit 60: Piramal Enterprises- Business segments
  • Exhibit 61: Piramal Enterprises- Organizational developments
  • Exhibit 62: Piramal Enterprises- Geographic focus
  • Exhibit 63: Piramal Enterprises- Segment focus
  • Exhibit 64: Piramal Enterprises- Key offerings
  • Exhibit 65: Sun Pharmaceutical Industries overview
  • Exhibit 66: Sun Pharmaceutical Industries- Business segments
  • Exhibit 67: Sun Pharmaceutical Industries- Organizational developments
  • Exhibit 68: Sun Pharmaceutical Industries- Geographic focus
  • Exhibit 69: Sun Pharmaceutical Industries- Segment focus
  • Exhibit 70: Sun Pharmaceutical Industries- Key offerings
Back to Top
전화 문의
F A Q